Related Experiment Video
Updated: Aug 4, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Serum lipoprotein (a) in men with proteinuria due to idiopathic membranous nephropathy
C D Short1, P N Durrington, N P Mallick
1Department of Renal Medicine, Royal Infirmary, Manchester, UK.
Insights
Patients with active proteinuria show elevated levels of Lipoprotein (a) (Lp(a)), a factor linked to heart disease and thrombosis. This finding may explain increased vascular risks in these patients.
Area of Science:
- Nephrology
- Cardiology
- Lipid Metabolism
Background:
- Proteinuria is associated with increased risks of venous thrombosis and coronary heart disease (CHD).
- Patients with heavy proteinuria often display altered lipoprotein metabolism.
- Lipoprotein (a) (Lp(a)) is a known risk factor for CHD and may promote thrombosis.
Purpose of the Study:
- To investigate serum Lipoprotein (a) (Lp(a)) concentrations in men with active idiopathic membranous nephropathy (IMN) compared to those in remission and healthy controls.
Main Methods:
- Serum Lp(a) levels were measured in three groups: 10 men with active IMN, 8 men with IMN in remission, and 103 healthy men.
- Statistical analysis was performed to compare Lp(a) levels across the groups.
Main Results:
- Serum Lp(a) levels were significantly elevated in men with active IMN (median 31.3 mg/dl) compared to men in remission (median 8.4 mg/dl) and healthy controls (median 11.3 mg/dl).
- Lp(a) levels in men with IMN in remission were similar to those in healthy controls.
Conclusions:
- Elevated serum Lp(a) levels are present in men with active idiopathic membranous nephropathy.
- High Lp(a) may contribute to the increased vascular morbidity (atherogenesis and thrombosis) observed in patients with proteinuria.
Abstract:
Patients with heavy proteinuria have an increased incidence of venous thrombosis and coronary heart disease (CHD). They also exhibit perturbations in lipoprotein metabolism. Lipoprotein (a) (Lp(a)) predisposes to CHD; it may also promote intravascular thrombosis since it contains apolipoprotein (a), which could act as a competitive inhibitor of plasminogen activation. We have measured the concentration of serum Lp(a) in 10 men with proteinuria due to idiopathic membranous nephropathy (IMN), in eight men with a similar diagnosis but who were in remission, and in 103 healthy men. Serum Lp(a) levels were significantly elevated in the men with active IMN, having a median value of 31.3 (range 3.2-75.0) mg/dl, whereas they were 8.4 (3.4-31.5) mg/dl in the patients in remission, which was similar to the value of 11.3 (< 0.8-87.4) mg/dl found in the healthy controls. Lp(a) is unique in containing an apolipoprotein which is a giant mutant of plasminogen and it is thus possible that the high circulating levels of Lp(a) contribute to the vascular morbidity associated with proteinuria by promoting thrombosis or atherogenesis or both.
More Related Videos
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Serum Studies: Renal Function Tests
Diabetic Nephropathy